Jagsonpal Accounts Payable vs Total Assets Analysis

JAGSNPHARM   639.65  23.25  3.77%   
Jagsonpal Pharmaceuticals financial indicator trend analysis is infinitely more than just investigating Jagsonpal Pharmaceuticals recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Jagsonpal Pharmaceuticals is a good investment. Please check the relationship between Jagsonpal Pharmaceuticals Accounts Payable and its Total Assets accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jagsonpal Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.

Accounts Payable vs Total Assets

Accounts Payable vs Total Assets Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Jagsonpal Pharmaceuticals Accounts Payable account and Total Assets. At this time, the significance of the direction appears to have no relationship.
The correlation between Jagsonpal Pharmaceuticals' Accounts Payable and Total Assets is 0.09. Overlapping area represents the amount of variation of Accounts Payable that can explain the historical movement of Total Assets in the same time period over historical financial statements of Jagsonpal Pharmaceuticals Limited, assuming nothing else is changed. The correlation between historical values of Jagsonpal Pharmaceuticals' Accounts Payable and Total Assets is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Accounts Payable of Jagsonpal Pharmaceuticals Limited are associated (or correlated) with its Total Assets. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Total Assets has no effect on the direction of Accounts Payable i.e., Jagsonpal Pharmaceuticals' Accounts Payable and Total Assets go up and down completely randomly.

Correlation Coefficient

0.09
Relationship DirectionPositive 
Relationship StrengthInsignificant

Accounts Payable

An accounting item on the balance sheet that represents Jagsonpal Pharmaceuticals obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Jagsonpal Pharmaceuticals are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.

Total Assets

Total assets refers to the total amount of Jagsonpal Pharmaceuticals assets owned. Assets are items that have some economic value and are expended over time to create a benefit for the owner. These assets are usually recorded in Jagsonpal Pharmaceuticals books under different categories such as cash, marketable securities, accounts receivable,prepaid expenses, inventory, fixed assets, intangible assets, other assets, marketable securities, accounts receivable, prepaid expenses and others. The total value of all owned resources that are expected to provide future economic benefits to the business, including cash, investments, accounts receivable, inventory, property, plant, equipment, and intangible assets.
Most indicators from Jagsonpal Pharmaceuticals' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Jagsonpal Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Jagsonpal Pharmaceuticals Limited. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
The Jagsonpal Pharmaceuticals' current Selling General Administrative is estimated to increase to about 72.9 M, while Tax Provision is projected to decrease to under 38.7 M.
 2021 2022 2023 2024 (projected)
Interest Expense2.6M4.1M8.1M7.7M
Depreciation And Amortization15.3M11.8M16.6M14.6M

Jagsonpal Pharmaceuticals fundamental ratios Correlations

-0.230.34-0.070.91-0.33-0.080.78-0.1-0.370.070.77-0.470.2-0.14-0.780.51-0.06-0.220.9-0.310.170.09-0.31-0.78-0.29
-0.23-0.620.55-0.580.870.9-0.44-0.570.610.27-0.490.82-0.080.340.12-0.43-0.20.94-0.470.94-0.07-0.61-0.250.30.72
0.34-0.620.110.5-0.42-0.570.470.42-0.31-0.240.4-0.460.05-0.74-0.170.320.05-0.510.4-0.450.050.320.36-0.33-0.55
-0.070.550.11-0.350.670.34-0.18-0.040.690.18-0.380.49-0.07-0.560.16-0.29-0.320.69-0.410.7-0.050.03-0.070.360.29
0.91-0.580.5-0.35-0.63-0.390.790.08-0.59-0.020.82-0.690.16-0.2-0.670.580.03-0.590.96-0.630.120.24-0.18-0.77-0.48
-0.330.87-0.420.67-0.630.74-0.65-0.420.860.17-0.720.89-0.420.090.22-0.68-0.130.93-0.580.95-0.41-0.460.040.550.79
-0.080.9-0.570.34-0.390.74-0.3-0.870.390.36-0.330.78-0.030.410.1-0.39-0.160.75-0.260.8-0.02-0.81-0.390.050.81
0.78-0.440.47-0.180.79-0.65-0.30.07-0.650.020.91-0.680.58-0.2-0.640.69-0.09-0.490.76-0.560.560.23-0.38-0.85-0.57
-0.1-0.570.42-0.040.08-0.42-0.870.07-0.09-0.380.09-0.54-0.03-0.38-0.040.270.11-0.37-0.02-0.45-0.030.790.520.22-0.75
-0.370.61-0.310.69-0.590.860.39-0.65-0.09-0.08-0.780.68-0.54-0.140.24-0.62-0.170.78-0.660.76-0.52-0.020.070.740.65
0.070.27-0.240.18-0.020.170.360.02-0.38-0.08-0.040.220.05-0.030.27-0.39-0.240.180.080.220.05-0.16-0.25-0.060.13
0.77-0.490.4-0.380.82-0.72-0.330.910.09-0.78-0.04-0.780.66-0.01-0.710.79-0.02-0.580.8-0.660.640.15-0.23-0.94-0.61
-0.470.82-0.460.49-0.690.890.78-0.68-0.540.680.22-0.78-0.430.180.46-0.720.080.8-0.590.89-0.41-0.62-0.020.560.83
0.2-0.080.05-0.070.16-0.42-0.030.58-0.03-0.540.050.66-0.430.05-0.290.68-0.15-0.250.14-0.31.0-0.02-0.36-0.61-0.36
-0.140.34-0.74-0.56-0.20.090.41-0.2-0.38-0.14-0.03-0.010.180.05-0.13-0.070.230.18-0.040.110.05-0.5-0.09-0.10.29
-0.780.12-0.170.16-0.670.220.1-0.64-0.040.240.27-0.710.46-0.29-0.13-0.550.110.12-0.630.26-0.27-0.020.160.680.21
0.51-0.430.32-0.290.58-0.68-0.390.690.27-0.62-0.390.79-0.720.68-0.07-0.55-0.02-0.530.52-0.560.650.2-0.21-0.64-0.61
-0.06-0.20.05-0.320.03-0.13-0.16-0.090.11-0.17-0.24-0.020.08-0.150.230.11-0.02-0.150.08-0.19-0.14-0.050.38-0.01-0.11
-0.220.94-0.510.69-0.590.930.75-0.49-0.370.780.18-0.580.8-0.250.180.12-0.53-0.15-0.510.96-0.23-0.39-0.090.440.65
0.9-0.470.4-0.410.96-0.58-0.260.76-0.02-0.660.080.8-0.590.14-0.04-0.630.520.08-0.51-0.550.10.08-0.17-0.8-0.45
-0.310.94-0.450.7-0.630.950.8-0.56-0.450.760.22-0.660.89-0.30.110.26-0.56-0.190.96-0.55-0.29-0.51-0.090.50.72
0.17-0.070.05-0.050.12-0.41-0.020.56-0.03-0.520.050.64-0.411.00.05-0.270.65-0.14-0.230.1-0.29-0.01-0.35-0.58-0.35
0.09-0.610.320.030.24-0.46-0.810.230.79-0.02-0.160.15-0.62-0.02-0.5-0.020.2-0.05-0.390.08-0.51-0.010.10.15-0.64
-0.31-0.250.36-0.07-0.180.04-0.39-0.380.520.07-0.25-0.23-0.02-0.36-0.090.16-0.210.38-0.09-0.17-0.09-0.350.10.28-0.28
-0.780.3-0.330.36-0.770.550.05-0.850.220.74-0.06-0.940.56-0.61-0.10.68-0.64-0.010.44-0.80.5-0.580.150.280.36
-0.290.72-0.550.29-0.480.790.81-0.57-0.750.650.13-0.610.83-0.360.290.21-0.61-0.110.65-0.450.72-0.35-0.64-0.280.36
Click cells to compare fundamentals

Jagsonpal Pharmaceuticals Account Relationship Matchups

Jagsonpal Pharmaceuticals fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.5B1.6B1.7B1.9B2.2B1.7B
Short Long Term Debt Total37.9M46.6M67.9M60.0M89.4M165.5M
Other Current Liab155.5M117.4M4.6M183.3M88.5M78.7M
Total Current Liabilities328.3M404.0M341.6M275.7M191.3M361.4M
Total Stockholder Equity1.1B1.2B1.3B1.6B1.9B1.2B
Property Plant And Equipment Net239.6M233.5M223.7M242.8M93.0M88.4M
Net Debt(334.1M)(518.4M)(251.4M)(50.5M)(38.2M)(36.3M)
Retained Earnings476.9M585.9M675.2M945.4M1.0B1.1B
Cash380.7M586.3M251.4M110.5M127.6M199.6M
Non Current Assets Total520.4M437.3M576.8M303.9M178.2M169.3M
Non Currrent Assets Other(353.8M)38.3M29.2M27.2M38.2M40.1M
Cash And Short Term Investments380.7M618.8M472.8M1.1B1.5B1.6B
Net Receivables224.5M126.6M155.8M221.1M109.5M104.0M
Liabilities And Stockholders Equity1.5B1.6B1.7B1.9B2.2B1.7B
Non Current Liabilities Total30.9M18.8M34.4M84.8M105.5M87.4M
Inventory293.3M297.2M297.4M206.8M150.0M247.3M
Other Current Assets274.5M143.6M80.6M41.9M363.2M381.4M
Total Liab359.2M422.7M376.0M360.6M296.8M350.2M
Total Current Assets949.1M1.2B1.1B1.6B2.0B1.1B
Accumulated Other Comprehensive Income(337.4M)1.1B496.9M506.5M588.7M618.2M
Short Term Debt64.0M67.9M7.5M7.5M13.8M13.1M
Accounts Payable117.1M180.5M185.5M78.5M76.0M96.0M
Current Deferred Revenue92.1M137.5M(7.5M)81.4M12.9M12.3M
Other Liab30.9M18.8M34.4M32.4M29.1M26.0M
Net Tangible Assets1.1B1.2B1.3B1.6B1.8B1.2B
Other Assets170.1M82.9M147.0M20.3M23.4M22.2M
Property Plant Equipment239.6M233.5M223.7M242.8M218.5M258.8M
Cash And Equivalents398.1M589.4M232.3M110.5M127.1M242.0M
Net Invested Capital1.2B1.3B1.3B1.6B1.9B1.5B
Net Working Capital620.8M800.8M766.2M1.4B1.8B1.1B

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Jagsonpal Stock

Balance Sheet is a snapshot of the financial position of Jagsonpal Pharmaceuticals at a specified time, usually calculated after every quarter, six months, or one year. Jagsonpal Pharmaceuticals Balance Sheet has two main parts: assets and liabilities. Liabilities are the debts or obligations of Jagsonpal Pharmaceuticals and are divided into current liabilities and long term liabilities. An asset, on the other hand, is anything of value that can be converted into cash and which Jagsonpal currently owns. An asset can also be divided into two categories, current and non-current.